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The Sec-dependent translocation pathway that involves the essential SecA protein and the membrane-bound
SecYEG translocon is used to export many proteins across the cytoplasmic membrane. Recently, several
pathogenic bacteria, including Mycobacterium tuberculosis, were shown to possess two SecA homologs, SecA1
and SecA2. SecA1 is essential for general protein export. SecA2 is specific for a subset of exported proteins and
is important for M. tuberculosis virulence. The enzymatic activities of two SecA proteins from the same
microorganism have not been defined for any bacteria. Here, M. tuberculosis SecA1 and SecA2 are shown to
bind ATP with high affinity, though the affinity of SecA1 for ATP is weaker than that of SecA2 or Escherichia
coli SecA. Amino acid substitution of arginine or alanine for the conserved lysine in the Walker A motif of
SecA2 eliminated ATP binding. We used the SecA2(K115R) variant to show that ATP binding was necessary
for the SecA2 function of promoting intracellular growth of M. tuberculosis in macrophages. These results are
the first to show the importance of ATPase activity in the function of accessory SecA2 proteins.
Mycobacterium tuberculosis is the causative agent of the dis-
ease tuberculosis (TB). TB kills about 2 million people annu-
ally, and approximately one-third of the world’s population is
currently infected with M. tuberculosis (40). A serious problem
in the worldwide fight against TB is the emergence of multi-
drug-resistant strains of M. tuberculosis. To develop logical
targets for new, effective drugs, the physiology of mycobacteria
must be better understood.
As with all bacterial pathogens, the majority of M. tubercu-
losis virulence factors are extracytoplasmic proteins exported
to the bacterial cell surface or secreted further to the extracel-
lular milieu (11, 21, 24). Bacteria possess several different
pathways for exporting proteins from the cytoplasm, including
the highly conserved Sec pathway (8, 24). The Sec pathway
uses the SecA protein and the membrane-integrated SecYEG
translocon to transport precursor proteins that contain a char-
acteristic amino-terminal signal sequence across the cytoplas-
mic membrane (18). SecA, an essential ATPase found in all
bacteria, undergoes conformational changes upon ATP bind-
ing and hydrolysis that drive the transport of unfolded precur-
sor proteins through the SecYEG translocon (36, 37). The
well-characterized ATPase activity of Escherichia coli SecA is
absolutely required for protein export and is stimulated by the
addition of phospholipids and by the presence of precursor
protein (27, 29, 39).
Most bacteria, including the model organisms E. coli and
Bacillus subtilis, possess a single, essential SecA protein. Re-
cently, several microorganisms, including M. tuberculosis, Lis-
teria monocytogenes, corynebacteria, and some streptococci,
were found to carry two SecA proteins, SecA1 and SecA2 (2–5,
7, 26). At the amino acid level, SecA1 and SecA2 of M. tuber-
culosis are about 50% similar to each other and 61% and 50%
similar to E. coli SecA, respectively (3). The mycobacterial
SecA1 protein is essential and is thought to function similarly
to the single SecA proteins of E. coli and B. subtilis (3, 16). The
mycobacterial SecA2 protein is not essential for growth in
culture but is required for exporting a subset of proteins (3, 4,
14). Furthermore, the secA2 deletion mutant of M. tuberculosis
is attenuated in virulence, suggesting that some of the SecA2-
dependent exported proteins are virulence factors (4, 22). In-
terestingly, the proteins exported by SecA2 systems in different
bacteria include examples with and without amino-terminal
signal sequences (1, 2, 4, 7, 22, 25).
The features that distinguish the function of SecA1 from
that of SecA2 in a single bacterial species are not known, nor
have the biochemical properties of each SecA been studied
previously. Here, we report that the SecA1 and SecA2 proteins
of M. tuberculosis are present at comparable levels, indicating
that expression levels do not explain the different functions of
these proteins.
Both SecA1 and SecA2 exhibit high sequence homology with
other SecA proteins in the Walker A and B motifs commonly
found in ATPases (38). The Walker motifs are part of the
motor domain of SecA. In structural studies, the motor domain
of M. tuberculosis SecA1 also shows the highest similarity to
that of B. subtilis SecA (32). Using purified M. tuberculosis
SecA1 and SecA2 proteins, we show that both proteins exhibit
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fully functional ATPase activities. Moreover, replacement of
the conserved lysine residue in the Walker A motif of SecA2 to
produce the SecA2(K115R) or the SecA2(K115A) variant
eliminates ATP binding. This amino acid replacement in the
Walker A motif also affects the biological activity of SecA2, as
the secA2(K115R) variant fails to complement the intracellular
growth defect of the M. tuberculosis secA2 mutant in macro-
phages. Our data present the first report of the characteriza-
tion of the ATPase activity for any SecA2 protein and show
that ATP binding is necessary for SecA2 function. This work
represents an important first step toward understanding how
the two SecA proteins in mycobacteria function in protein
translocation.
MATERIALS AND METHODS
Plasmids and strains. The E. coli SecA expression vector was a gift from Linda
Randall (31). The M. tuberculosis SecA1 expression vector was a gift from James
Sacchettini. The SecA1 plasmid was generated by PCR amplification of the
secA1 gene from M. tuberculosis H37Rv genomic DNA into pET29a (Novagen).
A stop codon was added to the 3 end of the gene to avoid addition of the
C-terminal hexahistidine tag from the plasmid. The SecA2 expression plasmid
was constructed by PCR amplification of the secA2 gene from M. tuberculosis
H37Rv genomic DNA, using the primers 5 CATTAATGGTGCCCAAGACC
ACCCGCGCTCA 3 and 5 TAAGCTTCAGCGGAACACCCCGGGCA
GACT 3. The resulting PCR product was cloned into pET41b (Novagen) to
create pNR14. This SecA2 expression vector uses an internal GTG start codon
located at nucleotide position 91 relative to the annotated start site (NCBI
accession number NP_216337). We believe this represents the true start codon.
Translation from this codon results in a protein whose sequence more closely
resembles that of SecA2 from other mycobacteria, and the corresponding shorter
SecA2 sequence can complement the secA2 mutant phenotypes in Mycobacte-
rium smegmatis and M. tuberculosis (data not shown). Plasmids that overexpress
SecA1 or SecA2 were transformed into E. coli BL21(DE3).
The Walker A motif of M. tuberculosis SecA2 was mutated in plasmid pNR14,
using a QuikChange site-directed mutagenesis kit (Stratagene). The primers
used to change lysine 115 (AAG) to arginine (AGG) (underlined) were 5
CGGTGAGGGCAGAACCCTTGCC 3 and 5 CGGCAAGGGTTCTGCCCT
CACC 3. The resulting SecA2(K115R) expression vector for E. coli is plasmid
pNR24. To create the same substitution in a mycobacterial expression vector,
pMB162 was used as a template to create pNR7. Plasmid pMB162 contains the
M. tuberculosis secA2 open reading frame, as annotated in the genome database,
under control of the constitutive mycobacterial hsp60 promoter and an attach-
ment site that enables stable integration into the mycobacterial genome in a
single copy (4). To generate the SecA2(K115A) pNR60 expression vector, site-
directed mutagenesis was performed with pNR24 with the primers 5 CGGTG
GCGGCAGAACCCTTGCC 3 and 5 CGGCAAGGGTTCTGCCGCCACC
3. Sequencing was used to confirm the appropriate secA2 sequence in all vectors
used in this study (Eton Biosciences).
Purification of proteins. E. coli SecA was expressed and purified as described
previously (10). Purification of M. tuberculosis SecA1 and SecA2 followed essen-
tially the same protocol. Freshly transformed cells were selected for the ability to
overproduce each protein. The cultures that overproduced the SecA proteins
were pooled and used for the protein preparation. The induced cells were
suspended in 25 mM Tris (pH 7.6), 10 mM magnesium acetate, and 10 mM NaCl
and lysed, using a French pressure cell at 15,000 lb/in2, into a 2 g/ml final
concentration of pepstatin A, leupeptin, and aprotinin, and 0.5 mM phenylmeth-
ylsulfonyl fluoride (PMSF) (Sigma). The lysate was clarified by low-speed cen-
trifugation, and the supernatants were centrifuged in a Sorvall T-865 rotor at
115,000  g for 3 h to remove the cell membranes.
For the purification of SecA1 and SecA2, the supernatant was applied to a
Blue-Sepharose CL-6B column (Pharmacia Biotech) equilibrated with 25 mM
Tris at pH 7.6, 0.5 mM EDTA, 100 M dithiothreitol, and 0.5 mM PMSF. The
protein was eluted with a step gradient consisting of a low-salt (the same buffer
supplemented with 10 mM NaCl), a medium-salt (0.4 M NaCl), and a high-salt
(1.3 M NaCl) buffer. Fractions containing SecA1 were collected, precipitated
with ammonium sulfate at 60%, and dialyzed against 10 mM HEPES (pH 7.6),
25 mM potassium acetate, 0.5 mM EDTA, and 100 M tris(2-carboxyethyl)phos-
phine (TCEP)-HCl (Pierce). SecA2 was concentrated by using an Amicon ul-
trafiltration stirred cell and a membrane with a molecular weight (MW) cutoff of
30,000. The purified protein was stored in aliquots at 80°C. The SecA2(K115R)
and SecA2(K115A) variant proteins were purified by the same method as that
used for the wild-type (WT) SecA2.
Quantification of the ratio of SecA2 to SecA1 in vivo. Whole-cell lysates of
exponential phase M. tuberculosis cultures grown in Middlebrook 7H9 medium
were prepared following fixation in an equal volume of 10% formalin for 1 h.
Fixed cells were pelleted by centrifugation, resuspended in extraction buffer, and
lysed by bead beating. For quantitative SecA1 and SecA2 Western blot analysis,
100 g of formalin-fixed whole-cell lysates were run on a 12% sodium dodecyl
sulfate (SDS)-polyacrylamide gel alongside a standard curve of known amounts
of purified SecA1 or SecA2 protein. Proteins were transferred to nitrocellulose
membranes and probed with rabbit polyclonal anti-SecA1 (1:50,000 dilution) or
anti-SecA2 (1:20,000 dilution) antibody (16). The secondary antibody was goat
anti-rabbit conjugated to alkaline phosphatase (1:20,000 dilution), and detection
of the fluorescence from ECF (Amersham/GE Healthcare) was done with a
PhosphorImager (Molecular Dynamics). The signal intensity values from six
independently prepared whole-cell lysates were quantified by comparison with
standard curve values to determine the number of moles of SecA1 and SecA2 per
mg of cellular protein.
Circular dichroism spectra. Circular dichroism (CD) was measured with an
Applied Photophysics Pi-Star 180 circular dichroism spectrapolarimeter, with the
cuvette maintained at 20°C with a circulating water bath. A 1-cm-path-length
quartz cuvette was used. The protein concentration was 0.1 mg/ml in 20 mM
phosphate buffer. The slits were set at 2 nm. The CD spectrum was taken from
250 to 200 nm with a 1-nm step size. The signal was averaged for 500,000 samples
for a total of 12.5 s at each wavelength.
Determination of melting temperature. CD at 222 nm was used to monitor the
secondary structure of the SecA proteins. The protein concentration was 0.1
mg/ml. To determine the melting temperature, the temperature was ramped
from 8°C to 65°C with a step size of 0.5°C. At each temperature, the signal at 222
nm was averaged for 100,000 points, which required around 10 s. The raw data
were normalized (12) to show the fraction unfolded at each temperature.
ATP binding assay. Nitrocellulose membrane filtration assays were used to
measure the ATP binding affinities of the SecA proteins as described in reference
42. The 0.2-M-pore-size nitrocellulose membranes (Whatman) were incubated
briefly with 0.5 N NaOH, rinsed extensively with deionized H2O, and then
equilibrated with binding buffer [50 mM HEPES-NaOH (pH 7.5), 30 mM KCl,
10 mM Mg(OAc)2] for at least 1 h. ATP stocks were prepared using Sigma
Ultrapure ATP and GE Healthcare [-32P]ATP. The protein concentration in
each assay was held between 3.7 and 4.5 M of monomer, and increasing
concentrations of ATP were added. The protein-ATP mixtures were incubated
on ice, which slows the ATPase activity to a rate undetectable by the use of the
malachite green assay, as described below. The solutions were filtered through
the nitrocellulose membrane to separate the bound ATP from the free ATP.
Because the apparent Kd (dissociation constant) values of E. coli SecA and M.
tuberculosis SecA2 for ATP were lower than the protein concentrations used in
the assays, the binding data were fitted with an equation used when there is
ligand depletion (15, 33), using the following equation: [LR]  [(Kd  [Rt] 
[Lt])  {(Kd  [Rt]  [Lt])2  4[Rt][Lt]}]/2, where Rt is the total protein
concentration and Lt is the total ATP added. The Kd value for SecA1 was
obtained by fitting the data to the standard equation for binding data, since here
the apparent Kd value was above the protein concentration used in the assay
equation [LR]  (Rt[L]) / (Kd  [L]), where L is the free ligand. The data were
fitted with KaleidaGraph software (Synergy Software). The Kd value was deter-
mined for each assay performed in triplicate, and the average Kd value and the
standard error were determined.
Analysis of ATPase activity. The protocol used to measure SecA ATPase
activity was a modification of the malachite green assay described previously (23,
27). A reaction mixture contained 40 g/ml of the SecA proteins, 1 mg/ml bovine
serum albumin, and 4 mM ATP in reaction buffer [50 mM Tris-HCl (pH 7.0), 30
mM KCl, 30 mM NH4Cl, 1 mM dithiothreitol, and 5 mM Mg(OAc)2]. The assay
was conducted at 25°C. Formation of inorganic phosphate was monitored spec-
trophotometrically by the increase in absorbance at 660 nm at each time point.
The inorganic phosphate concentration generated in the reaction mixture with
time was calculated using a standard curve. Each assay was done at least four
times with each protein. The rate of hydrolysis was determined for each assay
done in duplicate, and the averages and standard errors were determined.
Macrophage infections. Bone marrow macrophages were elicited from femurs
of C57BL/6 mice, as described previously (22, 28), and 2.5  105 macrophages
were seeded into wells of 8-well-chamber slides 24 h prior to infection. The M.
tuberculosis strains were grown to mid-exponential phase, washed with phos-
phate-buffered saline containing 0.05% Tween 80, diluted in tissue culture me-
dium (Dulbecco’s modified Eagle’s medium supplemented with 10% heat-inac-
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tivated fetal calf serum, 2 mM glutamine, and 1 nonessential amino acids
[Gibco]) and added to the macrophage monolayer to achieve a multiplicity of
infection of 1.0. Macrophage monolayers were infected with M. tuberculosis
strains for 4 h at 37°C in 5% CO2. On days 0, 1, and 5 postinfection, the contents
of triplicate wells for each infection were washed and then lysed with 0.05% SDS.
The resulting lysates were diluted and plated on Middlebrook 7H10 agar to
enumerate intracellular bacteria during the course of infection.
RESULTS
SecA1 and SecA2 proteins are present in equivalent
amounts in M. tuberculosis. The identification of bacteria that
possess two SecA proteins, such as M. tuberculosis, is a rela-
tively new discovery. As a starting point to understanding the
contribution of each SecA protein to the process of protein
export in M. tuberculosis, we determined the relative amounts
of SecA1 and SecA2 inside the bacterial cell. Quantitative
immunoblot analysis was performed with whole-cell lysates
prepared from the virulent M. tuberculosis strain H37Rv, using
antibodies specific to each SecA protein. These antibodies
were raised against peptides specific for SecA1 or SecA2, and
they recognize only the respective protein (16). These antibod-
ies were used to determine the number of moles of SecA1 or
SecA2 protein per mg of cellular protein by comparison to a
standard curve for the purified M. tuberculosis SecA1 protein
or to that of the SecA2 protein. The results, from an evaluation
of six independent whole-cell lysates, revealed nearly equiva-
lent amounts of each protein. The ratio of the average number
of moles per mg of protein of SecA2 (2.07  1011) to that of
SecA1 (2.25  1011) across these experiments was 0.93 	
0.12 (standard error). This indicates that the differences be-
tween the functions of SecA1 and those of SecA2 in M. tuber-
culosis are not due to different levels of expression, at least
under standard laboratory conditions.
Purification of M. tuberculosis SecA1 and SecA2. The two
SecA proteins from any bacteria have not been biochemically
characterized. The SecA1 and SecA2 proteins of M. tubercu-
losis were expressed from a plasmid and purified from E. coli as
soluble proteins. SecA1 has a predicted MW of 106,000/mono-
mer, while SecA2 is smaller, with a predicted MW of 85,400/
monomer (3). E. coli SecA has a MW of 101,000/monomer. All
the proteins were purified to 
90% using Blue-Sepharose col-
umn chromatography (Fig. 1A). SecA2 bound less tightly to
this column than SecA1 or E. coli SecA did, eluting with 0.5 M
salt instead of 1.2 M. This change in binding to a pseudo-
affinity column for nucleotide-binding proteins suggested that
SecA2 might have an altered affinity for nucleotides.
We next determined if the purified M. tuberculosis SecA1
and SecA2 proteins had CD spectra consistent with folded
secondary and tertiary structures (Fig. 1B). Each of the pro-
teins exhibited the characteristic minima at 209 and 222 nm
associated with proteins with significant levels of helical struc-
ture. Tryptophan fluorescence spectra for all the proteins were
also consistent with a native tertiary structure with emission
maxima around 340 nm, which is typical for folded proteins
(data not shown). These results were expected for properly
folded SecA1 and SecA2 proteins, as the three-dimensional
structure of M. tuberculosis SecA1 is similar to that of B. subtilis
SecA and E. coli SecA (17, 30, 32) and the sequences of the
mycobacterial SecA proteins are highly homologous.
SecA1 and SecA2 are less stable to heat denaturation than
E. coli SecA. At the standard temperature (37°C) used for ATP
hydrolysis assays, we saw little ATPase activity for the M.
tuberculosis SecA proteins. Since the E. coli SecA ATPase
activity is temperature dependent because the protein is ther-
molabile (27), we reasoned that the low activity levels of SecA1
and SecA2 proteins could be due to lower thermal stability. To
characterize the thermal stability of the M. tuberculosis SecA1
and SecA2 proteins, we denatured the proteins with heat and
followed the melting transition by CD at 222 nm (Fig. 2). The
data were normalized to show the fraction unfolded at each
temperature (12). The melting temperature (Tm) for E. coli
SecA was 43°C, as shown previously (34). Both M. tubercu-
losis SecA1 and SecA2 were less stable to heat denaturation,
with Tms of 35°C, indicating a moderate decrease in the
stability of the M. tuberculosis SecA proteins compared to that
of E. coli SecA. Our data show that measurements of activity of
the recombinant M. tuberculosis SecA proteins must be done at








































FIG. 1. (A) SDS gel of the purified SecA proteins. SecA1, SecA2,
and E. coli SecA were purified as described in Materials and Methods.
The proteins were separated on a 10% SDS polyacrylamide gel. Mo-
lecular weight markers (MW, in thousands) are indicated on the right
side of the gel. (B) CD spectra of each SecA protein. The spectra were
obtained as described in Materials and Methods. The protein concen-
tration was 0.1 mg/ml in 20 mM phosphate buffer (pH 7.6).
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M. tuberculosis SecA1 and SecA2 bind ATP with different
affinities. To determine if SecA1 and SecA2 bind ATP as
anticipated for proteins carrying canonical Walker A motifs,
we used a standard nitrocellulose membrane binding assay
with [-32P]ATP to determine the affinity of each protein for
ATP (42). The protein concentration in each assay was held
constant, and increasing concentrations of ATP were added.
The solutions were filtered through a nitrocellulose membrane
to separate the bound ATP from the free ATP. Because the
apparent Kd values of E. coli SecA and M. tuberculosis SecA2
for ATP were lower than the protein concentrations used in
the assays, the binding data were fitted with an equation used
when there is ligand depletion, as described in Materials and
Methods and previously (15, 33). The Kd value of SecA1 for
ATP was obtained by fitting the data to the standard equation
for binding data, since here the apparent Kd value was above
the protein concentration used in the assay. Analysis of the
binding data (Fig. 3A) showed that E. coli SecA bound ATP
with a Kd value of 0.46 	 0.11 M, which is within the standard
error for a previously published value (42). M. tuberculosis
SecA2 bound ATP with a somewhat weaker affinity of 1.9 	 0.3
M. M. tuberculosis SecA1 bound ATP 10-fold more weakly
than SecA2, with a Kd value of 21.8 	 4.0 M.
An interesting observation is that SecA2 binds more weakly
to the Blue-Sepharose column than either E. coli SecA or
SecA1, even though its Kd value for ATP binding is similar to
that of E. coli SecA, which binds tightly to this column. This
observation suggests that the SecA2 binding site for the Ciba-
cron Blue dye, presumably the ATP binding site, may have a
different conformation than SecA1 or E. coli SecA.
SecA1 and SecA2 exhibit ATPase activity. To determine if
M. tuberculosis SecA1 and SecA2 hydrolyze ATP, we used a
malachite green assay, which measures the amount of free
inorganic phosphate produced over time (6, 9, 23, 29) (Fig.
3B). Because each of the Tms of the M. tuberculosis SecA
proteins was lower than that of E. coli SecA, all ATPase assays
were done at 25°C. The ATPase activity level of each protein
was determined in duplicate from at least four separate exper-
iments. While we did see some variability in the results of the
FIG. 2. M. tuberculosis SecA proteins have decreased thermostabil-
ity compared to that of E. coli SecA. To determine the melting tem-
peratures, the SecA proteins (0.1 mg/ml) were ramped from 8 to 65°C.
At each 0.5 °C increment in temperature, the CD at 222 nm was
measured. The CD signal was normalized to show the fraction un-
folded at each temperature.
FIG. 3. (A) SecA2 binds ATP with high affinity. The affinity of ATP
binding by SecA proteins was determined by a nitrocellulose mem-
brane filtration assay. The concentrations of bound and free ATP were
determined. The data were fitted using the binding equations de-
scribed in Materials and Methods to determine the Kd values. Since
the data were fitted using two different equations, the ATP concen-
tration on the x axis is the total ATP for the E. coli SecA and SecA2
proteins and the free ATP for SecA1. The binding assays were re-
peated at least three times for each protein. Shown here are the
averages and standard errors of the averages determined for the com-
bined data. (B) Endogenous ATPase activities of the M. tuberculosis
SecA proteins. The endogenous activity levels of the SecA proteins
were determined using a malachite green assay for the formation of
free inorganic phosphate. Each assay was done in duplicate and re-
peated at least four times to determine the average rates and standard
errors of the averages.
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FIG. 4. Effect of the K115R and K115A substitutions in the Walker A motif of SecA2 in vitro. (A) Alignment of Walker A motifs in SecA
proteins. Sequence alignment of the highly conserved Walker A motif from mycobacterial SecA1 and SecA2 to the well-characterized SecA
proteins of E. coli and B. subtilis. The conserved lysine residue that was mutated to generate SecA2(K115R) or SecA2(K115A) is shown in bold.
(B) ATP binding by SecA2(K115R) (KR) and SecA2(K115A) (KA). The ATP binding was measured as described in the legend to Fig. 3. The
binding data for WT SecA2 is the same as that shown in Fig. 3. (C) Endogenous ATPase activity of SecA2(K115R) and SecA2(K115A). The
average rates and standard deviations of the ATP hydrolysis by each protein were determined by using the malachite green assay for determination
of free inorganic phosphate, as described in the legend to Fig. 3. The WT SecA2 hydrolysis rate is the same as that shown in Fig. 3. The average
rates and standard deviations from all of the experiments are shown.
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ATPase assays, the trends were the same for all assays. With
assays done at 25°C, each of the SecA proteins was able to
hydrolyze ATP; the endogenous ATPase activity level of M.
tuberculosis SecA1 was similar to that of E. coli SecA, while
that of SecA2 was about threefold higher than E. coli SecA.
Amino acid substitutions in the Walker A motif of SecA2
affect ATP binding in vitro. Alignment of M. tuberculosis
SecA1 and SecA2 with the SecA of E. coli and B. subtilis
reveals high sequence identity across the characteristic Walker
A motif of ATPases (Fig. 4A) (3). Structural studies demon-
strate that the amino acids of this motif participate in ATP
binding (20, 37). In previous studies, site-directed mutagenesis
of the conserved lysine in the Walker A motif (K108 in E. coli
SecA and K106 in B. subtilis SecA) has shown it to be impor-
tant for SecA ATP binding (29, 35). The E. coli SecA ATPase
K108R mutant is defective in ATP binding and protein trans-
location in vitro, as well as biologically inactive in vivo as
demonstrated by the inability to complement an E. coli
temperature-sensitive secA allele (29). The B. subtilis SecA
(K106N) ATPase mutant is also unable to translocate pre-
cursor proteins in vivo (20).
To determine if ATP binding and ATPase activity in M.
tuberculosis SecA2 depend similarly on the Walker A motif, we
substituted arginine or alanine for the conserved lysine K115 in
the Walker A motif of M. tuberculosis SecA2 and purified the
corresponding proteins as described above. We tested the abil-
ity of the SecA(K115R) and SecA2(K115A) variants to bind
ATP (Fig. 4B). Both the K115R and the K115A substitutions
significantly decrease the ability of SecA2 to bind ATP. We
then tested the ATP hydrolysis activity of the SecA(K115R)
variant, using the malachite green assay. The endogenous
ATPase activity for the SecA2(K115R) variant was somewhat
higher than that for the WT SecA2. The SecA2(K115A) vari-
ant had an ATP hydrolysis rate lower than that of WT SecA2
(Fig. 4C). These in vitro results show that the Walker box of
SecA2 is required for efficient ATP binding, as predicted and
shown to be the case for other SecA proteins (20, 29, 35).
These data also indicate that a SecA2 variant in which lysine,
K115, has been replaced can be used to assess the importance
of ATP binding for the biological functions of SecA2 in M.
tuberculosis.
A substitution in the Walker A motif of SecA2 affects bio-
logical activity in M. tuberculosis. A secA2 mutant of M.
tuberculosis is attenuated for growth in macrophages and in
mice (3, 4). The biochemical data presented above and the
results of previous studies suggest that M. tuberculosis SecA2
functions as an ATPase to promote the export of a specific
subset of proteins that are important to pathogenesis. To test
this idea, we asked whether the secA2(K115R) allele encodes a
functional protein that is able to fulfill the function of SecA2 in
promoting the growth of M. tuberculosis in macrophages. The
secA2(K115R) allele was introduced into the M. tuberculosis
secA2 mutant in a single copy at the chromosomal attB site.
Murine bone marrow-derived macrophages were infected in
parallel with the parental M. tuberculosis strain H37Rv, the
secA2 mutant of M. tuberculosis, the secA2 mutant comple-
mented with the wild-type secA2 gene inserted at the attB
locus, or the secA2 mutant with secA2(K115R) (Fig. 5A). As
shown previously, H37Rv and the secA2-complemented strain
grew at similar rates in macrophages over a 5-day period of
infection, while the secA2 mutant failed to grow in macro-
phages (22). Unlike introduction of the WT secA2 gene at the
attB site, which promoted M. tuberculosis growth in macro-
phages, the introduction of secA2(K115R) in the secA2 mu-
tant failed to promote this growth. Importantly, Western blot
analysis confirmed that the secA2 mutant strains carrying WT
secA2(K115R) or secA2(K115R) expressed the SecA2 protein
at similar levels (Fig. 5B). In addition, the growth defect of the
secA2(K115R) strain in macrophages was specific, as this strain
did not exhibit a general growth defect when tested in 7H9
liquid medium (data not shown). These results indicate that
replacing the conserved lysine in the Walker A motif of SecA2
FIG. 5. (A) The secA2(K115R) allele does not complement the M.
tuberculosis secA2 mutant phenotype in macrophages. Murine bone
marrow-derived macrophages were infected at a multiplicity of infec-
tion of 1.0 with the strain H37Rv, the secA2 mutant, the secA2
mutant complemented by the addition of WT secA2, (secA2secA2),
and the secA2 mutant with secA2(K115R) (secA2secA2 KR). CFU
were determined by plating macrophage lysates at various times
postinfection. The infection was performed with triplicate wells for
each strain per time point, and the error bars represent means 	
standard deviations for the triplicate wells. The symbols for H37Rv and
the complemented strain are overlapping at most time points in the
graph presented. Data are representative of three independent exper-
iments. , data are statistically significantly different (P  0.05). (B) Ex-
pression of SecA1 and SecA2 in strains with different secA2 alleles.
Equal amounts of formalin-fixed whole-cell lysates of the M. tubercu-
losis H37Rv strain carrying an empty vector, the M. tuberculosis secA2
mutant with an empty vector, the secA2 mutant with the WT secA2
integrated at the chromosomal attB site (WT), and the secA2 mutant
with the secA2(K115R) allele integrated at the attB site (KR) were run
on SDS-polyacrylamide gels and subjected to Western blot analysis
with anti-SecA1 or anti-SecA2 antibodies. The top panel shows SecA1
protein and the lower panel shows SecA2 protein. MW, molecular
weight (in thousands).
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renders SecA2 inactive in its biological role of promoting M.
tuberculosis growth in macrophages.
DISCUSSION
Here we report the first description of ATPase activities for
two SecA proteins from the same bacterium and the first de-
scription of the ATPase activity for any SecA2 protein. Based
on amino acid sequence analysis, M. tuberculosis SecA1 and
SecA2 possess the consensus Walker A and B motifs (3) that
are found in ATP hydrolyzing enzymes and are essential to E.
coli and B. subtilis SecA functions (20, 29). However, for
SecA2, which currently has an undefined role in protein export
and differs from the well-characterized E. coli SecA protein in
being nonessential in mycobacteria, the question of whether it
functions as an ATPase remains unanswered (4).
Here we demonstrated that both SecA proteins of M. tuber-
culosis are ATP binding and hydrolyzing proteins. SecA2
bound ATP with an affinity that was somewhat weaker than
that of E. coli SecA, and SecA1 bound ATP about 10-fold
more weakly than SecA2. Since the ATP concentration within
an M. tuberculosis cell is approximately 1 mM (13, 19), even
with these different affinities, both SecA proteins should be
fully saturated with ATP in vivo. Therefore, the physiological
significance of these differences in affinity is unclear.
The M. tuberculosis SecA proteins showed a lower melting
temperature than E. coli SecA under our buffer conditions,
suggesting that the M. tuberculosis SecA proteins are less ther-
mostable than E. coli SecA. Therefore, all of the ATP hydro-
lysis assays were done at a temperature at which the proteins
maintained their native state. At 25°C, each of the SecA pro-
teins was able to hydrolyze ATP. Although it is difficult to
directly compare results of ATP hydrolysis activities of SecA
proteins from different species because of the use of different
experimental conditions, our results are in general agreement
with the ATP hydrolysis rates of SecA proteins from Pseudo-
monas aeruginosa (41), E. coli (29), and B. subtilis (35). Nev-
ertheless, our data suggest that there may be some functional
differences between SecA1 and SecA2 with regard to ATP
affinities and hydrolysis rates. The endogenous ATPase activity
of M. tuberculosis SecA2 was found to be higher than that of M.
tuberculosis SecA1 and E. coli SecA.
The K115R substitution in the SecA2 Walker A motif
clearly establishes the fact that ATP binding of SecA2 is
vital for its function in vivo, as this substitution in SecA2
abolished the ability of M. tuberculosis to grow within mac-
rophages. In an ATP binding assay, the SecA2(K115R) and
SecA2(K115A) variants exhibited significantly reduced ATP
binding, as anticipated when the conserved lysine of Walker
A motif was replaced. However, neither the substitution of
R for K nor A for K eliminated the endogenous ATPase
activity. The K115R substitution slightly increased the en-
dogenous rate of ATP hydrolysis, while the SecA2(K115A)
variant showed about 60% of the activity of WT SecA2.
These results are consistent with those of Mitchell and Oliver
(29), where the E. coli SecA(K108R) substitution in the Walker
A motif affected biological activity and eliminated effective
ATP binding but did not eliminate—and even somewhat in-
creased—the endogenous ATPase activity (29).
The mycobacterial SecA proteins have been shown to be
functionally dissimilar from one another in that SecA2 partic-
ipates only in the export of a specific subset of proteins (3, 4,
14). The data presented here indicate that both M. tuberculosis
SecA1 and SecA2 are ATPases. Our data suggest that each M.
tuberculosis SecA protein is likely to function in a manner
similar to that of E. coli SecA in undergoing cycles of ATP
binding and hydrolysis-promoted conformational changes that
drive protein export across the cytoplasmic membrane. In ad-
dition, we show that the levels of SecA1 and SecA2 in the cell
are equivalent. Therefore, the functional differences between
SecA1 and SecA2 may be at the level of the specific proteins
they recognize for export or the proteins with which they in-
teract to form a translocation complex. For SecA1, we believe
the protein works in concert with the membrane-localized
SecYEG translocon. The SecA2 protein may also work with
SecYEG or with an as-yet unidentified translocation com-
plex to selectively export a subset of proteins. Alternatively,
differences in the function of the SecA proteins might be in the
regulation of their enzymology. The studies here lay the
groundwork for further investigation of the SecA2 export path-
way of mycobacteria.
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